SIGYN THERAPEUTICS, INC. Payments to Acquire in Process Research and Development
SIGYN THERAPEUTICS, INC. (SIGY) reported Payments to Acquire in Process Research and Development of $10.80 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-21.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment · last filed 2022-03-21
- SIGYN THERAPEUTICS, INC. payments to acquire in process research and development for the quarter ending 2020-12-31 was $0.00.
- SIGYN THERAPEUTICS, INC. payments to acquire in process research and development for the quarter ending 2020-09-30 was $9.50K.
- SIGYN THERAPEUTICS, INC. payments to acquire in process research and development for the quarter ending 2020-06-30 was $0.00.
- SIGYN THERAPEUTICS, INC. payments to acquire in process research and development for the quarter ending 2020-03-31 was $1.30K.
- SIGYN THERAPEUTICS, INC. payments to acquire in process research and development for fiscal 2020 was $10.80K.
| Period end | Payments to Acquire in Process Research and Development 3 month | Payments to Acquire in Process Research and Development 6 month | Payments to Acquire in Process Research and Development 9 month | Payments to Acquire in Process Research and Development 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $9.50K derived: sum of 2 quarters · filed 2022-03-21 | $9.50K derived: sum of 3 quarters · filed 2022-03-21 | $10.80K 10-K · filed 2022-03-21 |
| 2020-09-30 | $9.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $9.50K derived: sum of 2 quarters · filed 2021-11-12 | $10.80K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $1.30K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $1.30K 10-Q · filed 2021-05-17 |